Dry Eye Disease

Ophthalmology·MeSH: Dry Eye Syndromes

14 drugs in development·9 companies·5 clinical trials

Drug Pipeline by Phase

Approved(4)

Drug	Company
MIEBO	Bausch Health Companies Inc. (BHC)
Ocular Immunoglobulin E (IgE)	AXIM BIOTECHNOLOGIES, INC. (AXIM)
Ocular Lactoferrin (Lf)	AXIM BIOTECHNOLOGIES, INC. (AXIM)
XIIDRA	Bausch Health Companies Inc. (BHC)

Phase 3(6)

Drug	Company
0.003% ar-15512	AERIE PHARMACEUTICALS INC (AERI)
ABBV-444	AbbVie Inc. (ABBV)
ar-15512	AERIE PHARMACEUTICALS INC (AERI)
ar-15512 vehicle	AERIE PHARMACEUTICALS INC (AERI)
pl9643	PALATIN TECHNOLOGIES INC (PTN)
REFRESH OPTIVE UD	AbbVie Inc. (ABBV)

Phase 2(3)

Unknown(1)

Drug	Company
filing	Aldeyra Therapeutics, Inc. (ALDX)

BioSniper tracks 14 drugs in development for Dry Eye Disease across 9 companies.

There are 5 clinical trials targeting Dry Eye Disease tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.